J Rheum Dis 2016; 23(2): 88-95
Published online April 30, 2016
© Korean College of Rheumatology
Correspondence to : Seung-Cheol Shim
Division of Rheumatology, Department of Medicine, Daejeon Rheumatoid and Degenerative Arthritis Center, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea. E-mail:shimsc@cnuh.co.kr
Objective. The objective of this study is to assess whether genetic functional variants of disintegrin and metalloprotease 33 (ADAM33) are associated with susceptibility to systemic lupus erythematosus (SLE) in a Korean population. Methods. We previously identified 48 single nucleotide polymorphisms (SNPs) in ADAM33. Six SNPs were selected with regard to the linkage disequilibrium pattern. An association study of ADAM33 was conducted in 190 patients with SLE and 469 control subjects. SNPs were genotyped using the TaqMan Real-time polymerase chain reaction method, and haplotype analyses of related variants were performed. Results. All SNPs were in Hardy-Weinberg equilibrium. Significant associations were found between the ADAM33 polymorphisms and SLE at rs2787094 (adjusted odds ratio [OR] 1.88, 95% confidence interval [CI] 1.00 to 3.54; p< 0.0001). The rs554743 polymorphism was associated with the presence of the immunoglobulin M anti-cardiolipin antibody (adjusted OR 0.29, 95% CI 0.10 to 0.83; p=0.021). Conclusion. ADAM33 polymorphisms were associated with susceptibility to SLE and development of clinical disease manifestations in a Korean population. Further study is warranted to clarify the role of ADAM33 in SLE pathogenesis. (J Rheum Dis 2016;23:88-95)
Keywords Disintegrin and metalloproteinase domain 33 protein, Systemic lupus erythematosus, Single nucleotide polymorphism
J Rheum Dis 2016; 23(2): 88-95
Published online April 30, 2016
Copyright © Korean College of Rheumatology.
Ji-Young Kim1*, Young Kim1*, Soo-Cheon Chae2, Shin-Seok Lee3, Mi-Kyoung Lim4, Dong-Huyk Sheen4, Hun-Taeg Chung5, Seung-Cheol Shim1
1Division of Rheumatology, Department of Medicine, Daejeon Rheumatoid and Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, 2Department of Pathology, Wonkwang University School of Medicine, Iksan, 3Division of Rheumatology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 4Department of Medicine, Eulji Medi-Bio Research Institute, Eulji University, Daejeon, 5School of Biological Sciences, University of Ulsan, Ulsan, Korea
Correspondence to:Seung-Cheol Shim
Division of Rheumatology, Department of Medicine, Daejeon Rheumatoid and Degenerative Arthritis Center, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea. E-mail:shimsc@cnuh.co.kr
Objective. The objective of this study is to assess whether genetic functional variants of disintegrin and metalloprotease 33 (ADAM33) are associated with susceptibility to systemic lupus erythematosus (SLE) in a Korean population. Methods. We previously identified 48 single nucleotide polymorphisms (SNPs) in ADAM33. Six SNPs were selected with regard to the linkage disequilibrium pattern. An association study of ADAM33 was conducted in 190 patients with SLE and 469 control subjects. SNPs were genotyped using the TaqMan Real-time polymerase chain reaction method, and haplotype analyses of related variants were performed. Results. All SNPs were in Hardy-Weinberg equilibrium. Significant associations were found between the ADAM33 polymorphisms and SLE at rs2787094 (adjusted odds ratio [OR] 1.88, 95% confidence interval [CI] 1.00 to 3.54; p< 0.0001). The rs554743 polymorphism was associated with the presence of the immunoglobulin M anti-cardiolipin antibody (adjusted OR 0.29, 95% CI 0.10 to 0.83; p=0.021). Conclusion. ADAM33 polymorphisms were associated with susceptibility to SLE and development of clinical disease manifestations in a Korean population. Further study is warranted to clarify the role of ADAM33 in SLE pathogenesis. (J Rheum Dis 2016;23:88-95)
Keywords: Disintegrin and metalloproteinase domain 33 protein, Systemic lupus erythematosus, Single nucleotide polymorphism
Bong-Woo Lee, M.D., Eui-Jong Kwon, M.D., Ji Hyeon Ju, M.D., Ph.D.
J Rheum Dis -0001; ():So-Young Bang, M.D., Ph.D., Seung Cheol Shim, M.D., Ph.D.
J Rheum Dis 2024; 31(4): 200-211Alhanouf Adnan Alsharif, M.B.B.S., Abdulaziz Marzouq Almutairi, M.D., Emtenan Badar Basahl, M.B.B.S., Abdulaziz Abdulllah Alshathri, M.D., Jameela Abdulaziz Kari, M.D., Mohammed Ahmad Shalaby, M.D., Mohammed Ahmad Nashawi, M.D.
J Rheum Dis 2025; 32(1): 57-62